VIRAX BIOLABS GROUP LTD (VRAX) Stock Cash Flow
NASDAQ:VRAX - KYG9495L1251 - Common Stock
0.55 USD
-0.01 (-1.79%)
| 2025 (2025-3-31) | 2024 (2024-3-31) | 2023 (2023-3-31) | 2022 (2022-3-31) | 2021 (2021-3-31) | ||||
|---|---|---|---|---|---|---|---|---|
| CASH FLOWS FROM OPERATING ACTIVITIES | ||||||||
| Net Income | -6.07M | -6.74M | -5.46M | -1.75M | -670.00K | |||
| Depreciation Amortization | 343.40K | 103.10K | N/A | N/A | N/A | |||
| Change In Working Capital | 625.60K | -1.12M | -182.30K | 640.00K | 60.00K | |||
| Interest Paid | 79.00K | 6.10K | 15.50K | N/A | N/A | |||
| Taxes Paid | N/A | 0.00 | 0.00 | N/A | N/A | |||
| Other non cash items | 534.70K | 1.51M | 1.46M | 300.00K | 20.00K | |||
| OPERATING CASH FLOW | -4.56M | -6.25M | -4.18M | -810.00K | -590.00K | |||
| CASH FLOWS FROM INVESTING ACTIVITIES | ||||||||
| Capital Expenditure | -603.90K | -1.16M | -178.40K | N/A | N/A | |||
| INVESTING CASH FLOW | -603.90K | -1.16M | -178.40K | N/A | N/A | |||
| CASH FLOWS FROM FINANCING ACTIVITIES | ||||||||
| Debt Issued/Reduced | -107.80K | -206.30K | 146.30K | 100.00K | N/A | |||
| Stock Issued/Repurchased | 5.91M | 1.87M | 13.65M | 520.00K | 400.00K | |||
| Other Financing Activity | N/A | -18.30K | -111.70K | 190.00K | 180.00K | |||
| FINANCING CASH FLOW | 5.81M | 1.65M | 13.69M | 810.00K | 590.00K | |||
| CHANGE IN CASH | 639.70K | -5.76M | 9.33M | 0.00 | 0.00 | |||
| FREE CASH FLOW | ||||||||
| Operating Cash Flow | -4.56M | -6.25M | -4.18M | -810.00K | -590.00K | |||
| Capital Expenditure | -603.90K | -1.16M | -178.40K | N/A | N/A | |||
| FREE CASH FLOW | -5.17M | -7.41M | -4.36M | -810.00K | -590.00K | |||
All data in USD